Thomas Bleazard
Impact in
-
- SARS-CoV-2 and COVID-19 Research
-
- MicroRNA in disease regulation
Papers in
-
- SARS-CoV-2 and COVID-19 Research 2
-
- CRISPR and Genetic Engineering 1
- Glycosylation and Glycoproteins Research 1
- Genomics and Phylogenetic Studies 1
- Pluripotent Stem Cells Research 1
- Plant biochemistry and biosynthesis 1
- Co-authors
- Sam Griffiths‐Jones (1 shared paper)Janine A. Lamb (1 shared paper)Martin Fritzsche (3 shared papers)Ryan Mate (2 shared papers)Gregory C. A. Amos (1 shared paper)Sjoerd G. T. Rijpkema (1 shared paper)Alastair Logan (1 shared paper)Saba Anwar (1 shared paper)
- Journals
- Scientific Reports (2 papers)Bioinformatics (2 papers)Microbiome (1 paper)Experimental & Molecular Medicine (1 paper)Nature Communications (1 paper)
- Partner nations
- United KingdomSouth KoreaUnited States
In The Last Decade
Thomas Bleazard
13 papers receiving 686 citations
Peers
Comparison fields: 5 of 98
- Infectious Diseases 129
- Cancer Research 89
- Molecular Biology 339
- Pulmonary and Respiratory Medicine 87
- Cognitive Neuroscience 54
Countries citing papers authored by Thomas Bleazard
This map shows the geographic impact of Thomas Bleazard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Bleazard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Bleazard more than expected).
Fields of papers citing papers by Thomas Bleazard
This network shows the impact of papers produced by Thomas Bleazard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Bleazard. The network helps show where Thomas Bleazard may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Bleazard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 189 | |
| 2 | 2014 | 101 | |
| 3 | 2020 | 99 | |
| 4 | 2015 | 92 | |
| 5 | Guidelines for conducting research studies with the autism community. | 2019 | 64 |
| 6 | 2012 | 56 | |
| 7 | 2021 | 32 | |
| 8 | 2019 | 28 | |
| 9 | 2013 | 23 | |
| 10 | 2013 | 15 | |
| 11 | 2021 | 8 | |
| 12 | 2013 | 3 | |
| 13 | 2016 | 2 |
About Thomas Bleazard
Thomas Bleazard is a scholar working on Infectious Diseases, Molecular Biology, Cancer Research, Genetics and Plant Science, having authored 13 papers that have together received 712 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), CRISPR and Genetic Engineering (1 paper), Glycosylation and Glycoproteins Research (1 paper), Genomics and Phylogenetic Studies (1 paper), Cancer Genomics and Diagnostics (1 paper), Pluripotent Stem Cells Research (1 paper), Phytochemistry and biological activity of medicinal plants (1 paper) and Plant biochemistry and biosynthesis (1 paper). The work is most often cited by research in Infectious Diseases (129 citations), Cancer Research (89 citations), Molecular Biology (339 citations), Pulmonary and Respiratory Medicine (87 citations) and Cognitive Neuroscience (54 citations). Thomas Bleazard has collaborated with scholars based in United Kingdom, South Korea and United States. Frequent co-authors include Sam Griffiths‐Jones, Janine A. Lamb, Martin Fritzsche, Ryan Mate, Gregory C. A. Amos, Sjoerd G. T. Rijpkema, Alastair Logan, Saba Anwar, Young Seok Ju and Daniel H. Poole. Their work appears in journals such as Scientific Reports, Bioinformatics, Microbiome, Experimental & Molecular Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.